THOMAS PAUL 4

4 · TELA Bio, Inc. · Filed Jun 11, 2026

AI-generated summary of this filing

Updated Jun 11, 2026

TELA Bio Director Thomas Paul Receives Equity Awards

What Happened

Thomas Paul, a director of TELA Bio, received equity awards on June 9, 2026 totaling 58,485 units across restricted stock units (RSUs) and stock options. The grants were reported at $0.00 per share (no cash paid by the insider).
Breakdown: 11,925 RSUs, 11,675 RSUs, 17,550 option units (derivative), and 17,335 option units (derivative). These were reported as awards (transaction code A).

Key Details

Transaction date: June 9, 2026; Form 4 filed June 11, 2026 (filed timely).
Reported price: $0.00 for all grants (typical for awards/grants).
Shares/units after transaction: Not disclosed in the filing.
Vesting notes:
- 11,925 RSUs vest in three equal annual installments beginning June 9, 2027 (subject to continued service).
- 11,675 RSUs vest on the earlier of June 9, 2027, the next annual meeting, or a Change in Control (subject to continued service).
- 17,550 option units vest in 36 equal monthly installments beginning June 9, 2026 (subject to continued service).
- 17,335 option units vest on the earlier of June 9, 2027, the next annual meeting, or a Change in Control (subject to continued service).

Context

These grants are compensatory awards to a director and vest over time or upon specified events; they are not open-market purchases or sales. Such awards are common director compensation and do not by themselves indicate immediate buying or selling activity.

Form 4

Period: 2026-06-09

Director

Transactions

Award
Common Stock
[F1]
2026-06-09+11,925→ 11,925 total
Award
Common Stock
[F2]
2026-06-09+11,675→ 23,600 total
Award
Stock Option (Right to Buy)
[F3]
2026-06-09+17,550→ 17,550 total
Exercise: $0.94Exp: 2036-06-09→ Common Stock (17,550 underlying)
Award
Stock Option (Right to Buy)
[F4]
2026-06-09+17,335→ 17,335 total
Exercise: $0.94Exp: 2036-06-09→ Common Stock (17,335 underlying)

Footnotes (4)

[F1]These restricted stock units will vest in three equal annual installments beginning on June 9, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date.
[F2]These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
[F3]The option vests in 36 equal monthly installments on each monthly anniversary of June 9, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date.
[F4]The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Signature

/s/ Megan Smeykal, Attorney-in-Fact|2026-06-11

1 file